Legal Representation
Attorney
SEBASTIAN LOVERA, ESQ.
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 8, 2025 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Mar 7, 2025 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 |
| Feb 4, 2025 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Jan 7, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 7, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 1, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 13, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 8, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 8, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 8, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 30, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 30, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 15, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Aug 14, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 6, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| May 6, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| May 6, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Mar 28, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 010
Blood pressure monitors; Health monitoring devices, namely, blood pressure monitors, thermometers and pedometers; Heart monitors; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring oxymetory, gas analysis and vital signs; Medical devices for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; Medical devices for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events and software sold as a unit therewith; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical apparatus for preventing, reversing and treating chronic stable angina
First Use Anywhere:
20200500
First Use in Commerce:
20200500
Additional Information
Design Mark
The mark consists of the wording "BIOX" in stylized capital lettering with a symbol design to the left of the wording comprising two parallel, horizontal bars with a perpendicular, vertical bar bisecting the horizontal bars. The upper horizontal bar also has two shorter vertical bars extending upwards from each end. All of the bars are the same width.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
010